AgEagle Aerial Systems, Inc. (NYSE: UAVS) is a developer of commercial drones, services and solutions for various industries such as agriculture, critical infrastructure and last-mile delivery of goods and services. The Company is focused on three verticals namely Contract Manufacturing, Drone Solutions and Agriculture solutions. The...
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical developing cutting-edge therapies for the treatment of patients with kidney diseases, announced the acceptance of the filing of its New Drug Application (NDA) for its lead product candidate, Vadadustat, a hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, intended for...
Ribbon Communications, Inc. (NASDAQ: RBBN) provides comprehensive end-to-end communications and networking solutions such as session border controllers, policy routing and signaling, Intelligent Edge, uCPE, call controllers, XaaS and Media Gateways to enterprises across the globe. The Company caters to the needs of leading tier-one internet...
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to fruition. While Vaccine development and therapeutics to combat the COVID-19 pandemic are at the forefront of development activities in the biotech sector,...
Cinedigm Corp, (NASDAQ: CIDM), a leading streaming company, has signed a deal with MonteCristo International Entertainment, a wholly owned subsidiary of Broadside Enterprises, Inc, through which independent feature films will be made available on cinedigm’s streaming channels. The move seeks to leverage the extensive digital...
Scholar Rock Holding (NASDAQ: SRRK), a clinical-stage biopharmaceutical Company, announced the grant of a Fast-Track Designation for apitegromab, a selective inhibitor of myostatin activation, intended for the treatment of Spinal Muscular Atrophy (SMA) by the U.S. Food and Drug Administration (FDA). The candidate has previously...
Lordstown Motors Corp. (NASDAQ: RIDE) is taking a drubbing again, after reporting disappointing Q1 earnings, which included higher than expected forecasted expenses and lowering of the production forecast of its electric pickup. The forecast for Endurance, touted to be the first commercial vehicle to feature...
Scopus BioPharma, Inc. (NASDAQ: SCPS), a biopharmaceutical company, announced the approval of an investigational drug application (IND) for CpG-STAT3siRNA, an immuno-oncology RNA therapy intended for the treatment of multiple cancers. CpG-STAT3siRNA, or CO-sTiRNA™, the company’s lead product candidate is a first-in-class, targeted immuno-oncology gene therapy and...
While Industries across the globe are grappling with the pandemic and its impact on their operations, Technology Industry has been focused on minimizing the impact and marching ahead with its innovations and breakthroughs, be it electric charging, semiconductor solutions or critical communication systems. We take a...
A clinical stage Immuno-oncology company, Surface Oncology, Inc. (NASDAQ: SURF) is developing a diverse pipeline of candidates that target the immune system to combat various forms of cancer. The Company’s pipeline consists of candidates in four key areas namely macrophages and natural killer cells,...
